Contribute Try STAT+ Today

2021 STAT Summit

nov 16-18hybrid event

About

Charting a course for medicine's future

Join us for our signature STAT Summit event. As we gather the top minds in the life sciences, we'll bring to life the coverage that has earned STAT its reputation: deep analysis and fearless discussion around the most important topics in biotech, medicine, and policy, brought to you by the industry's top talent.

This November we will be offering a special in-person program and networking reception for Attendee Pass holders who are comfortable traveling for events. Read more about our ticket types below.

Speakers

Learn from authoritative speakers

Apply today to be considered for a speaking opportunity at the 2021 STAT Summit. More featured speakers will be announced soon!

Noubar Afeyan, Ph.D.

Noubar Afeyan, Ph.D.

Founder and CEO, Flagship Pioneering; Co-Founder & Chairman, Moderna

Liz Barrett
Sponsor Speaker

Liz Barrett

President and Chief Executive Officer, UroGen Pharma

Rick Berke
STAT MODERATOR

Rick Berke

Co-Founder & Executive Editor, STAT

Elisabeth Bik, Ph.D.

Elisabeth Bik, Ph.D.

Science Integrity Consultant

Teresa Bitetti
Sponsor Speaker

Teresa Bitetti

President, Global Oncology Business Unit, Takeda

Albert Bourla, DVM, Ph.D.

Albert Bourla, DVM, Ph.D.

Chairman and Chief Executive Officer, Pfizer

Helen Branswell
STAT Moderator

Helen Branswell

Senior Writer, Infectious Disease, STAT

David Chang, M.D., Ph.D.
Sponsor Speaker

David Chang, M.D., Ph.D.

President, Chief Executive Officer and Co-Founder of Allogene

Joia Crear-Perry, M.D., FACOG

Joia Crear-Perry, M.D., FACOG

Founder & President, National Birth Equity Collaborative

Kevin Conroy

Kevin Conroy

Chief Executive Officer, President, and Chairman of the Board, Exact Sciences

Giulio F. Draetta M.D., Ph.D.
SPONSOR SPEAKER

Giulio F. Draetta M.D., Ph.D.

Chief Scientific Officer, The University of Texas MD Anderson Cancer Center

Anthony Fauci, M.D.

Anthony Fauci, M.D.

Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health

Gideon Gil
STAT MODERATOR

Gideon Gil

Managing Editor, STAT

John D. Halamka, M.D., M.S.

John D. Halamka, M.D., M.S.

President, Mayo Clinic Platform

Linda Henry
STAT MODERATOR

Linda Henry

CEO, Boston Globe Media Partners

Matthew Herper
STAT Moderator

Matthew Herper

Senior Writer, Medicine; Editorial Director of Events, STAT

Paul Hudson
Sponsor Speaker

Paul Hudson

CEO, Sanofi

Ragul Kalluri, M.D., Ph.D.
Sponsor Speaker

Ragul Kalluri, M.D., Ph.D.

Chair of Cancer Biology, The University of Texas MD Anderson Cancer Center

James Kugler
Sponsor Speaker

James Kugler

CEO of EMD Digital and Director of Syntropy

Linsey Marr, Ph.D.

Linsey Marr, Ph.D.

Professor of Civil and Environmental Engineering, Virginia Tech

Folasade P. May, M.D., Ph.D., M.Phil.

Folasade P. May, M.D., Ph.D., M.Phil.

Assistant Professor of Medicine, University of California Los Angeles

Casey Ross
STAT Moderator

Casey Ross

National Technology Correspondent, STAT

Uwe Schoenbeck, Ph.D.
Sponsor Speaker

Uwe Schoenbeck, Ph.D.

Senior Vice President and Chief Scientific Officer, Emerging Science & Innovation (ES&I), Pfizer Worldwide R&D

Ramona Sequeira
Sponsor Speaker

Ramona Sequeira

President, Takeda Pharmaceuticals USA

Nigam H. Shah, MBBS, Ph.D.

Nigam H. Shah, MBBS, Ph.D.

Professor of Medicine, Stanford University; Associate CIO for Data Science, Stanford Health Care

Darryl Sleep, M.D.
SPONSOR SPEAKER

Darryl Sleep, M.D.

SVP, Global Medical and Chief Medical Officer, Amgen

Nicholas St. Fleur
STAT Moderator

Nicholas St. Fleur

General Assignment Reporter; Associate Editorial Director of Events, STAT

Robert Stone
Sponsor Speaker

Robert Stone

President & CEO, City of Hope

Megan Thielking
STAT MODERATOR

Megan Thielking

News Editor, STAT

Stephen J. Ubl
Sponsor Speaker

Stephen J. Ubl

President and Chief Executive Officer, PhRMA

Agenda

Join us from Nov. 16th to 18th

Agenda subject to change. Additional details and sessions to be announced!

November 16, 2021 - Hybrid

1:00 p.m. ET

Welcome from STAT

Virtual
Rick Berke, co-founder and executive editor, STAT

1:05 p.m. ET
Sponsor Speaker

Opening Remarks

Virtual
Ramona Sequeria, president, Takeda Pharmaceuticals USA

1:10 p.m. ET

Pfizer: Vaccines and beyond

Virtual
Albert Bourla, DVM, Ph.D., chairman and chief executive officer, Pfizer Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

Pfizer’s CEO, Albert Bourla, returns to the STAT Summit to reflect on the year that was. As the company continues to lead in Covid-19 vaccine production, he will discuss what’s next - from boosters and beyond.

1:35 p.m. ET

Catching up with Tony Fauci

Virtual
Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health Helen Branswell, senior writer, infectious disease, STAT (moderator)

As the deadly Covid-19 pandemic has dragged on, few voices have been as important as that of Anthony Fauci. He’ll join STAT’s Helen Branswell to discuss the past year and what to expect in the months ahead.

2:05 p.m. ET

Interstitial

Virtual

2:10 p.m. ET
Sponsor Session

Fireside chat

Virtual
Paul Hudson, CEO, Sanofi Rick Berke, co-founder and executive editor, STAT (moderator)

2:20 p.m. ET

Introducing the 2021 STAT Biomedical Innovation Award

Virtual
To be announced

This year's recipient of the STAT Biomedical Innovation award will be announced with an introduction from award sponsor, Pfizer.

Sponsor Introduction
Uwe Schoenbeck, Ph.D., senior vice president and chief scientific officer, emerging science & innovation (ES&I), Pfizer Worldwide R&D
2:40 p.m. ET

To be announced

Virtual

3:05 p.m. ET

Coffee Break

Virtual

3:20 p.m. ET
Sponsor Speaker

Spotlight Session

Virtual
Quita Highsmith, M.B.A., vice president and chief diversity officer, Genentech

3:25 p.m. ET

Confronting an American tragedy

Virtual
Joia Crear-Perry, M.D., FACOG, founder & president, National Birth Equity Collaborative Charles Johnson, Founder, 4kira4moms Nicholas St. Fleur, general assignment reporter, associate editorial director of events, STAT (moderator) Additional speakers to be announced

Black women are three times more likely to die during childbirth than white women. The causes are myriad and the solutions are long ignored. A look at the progress that is being made, both in research and at the highest echelons of government.

3:55 p.m. ET

Interstitial

Virtual

4:00 p.m. ET
Sponsor Session

Fireside chat

Virtual
Robert Stone, President & CEO, City of Hope Gideon Gil, managing editor, STAT (moderator)

4:10 p.m. ET

Hypebuster Elisabeth Bik

Virtual
Elisabeth Bik, Ph.D., science integrity consultant

There is no one better at spotting cases where researchers have modified or faked data involving images -- a talent that has led her to speak up against both big name researchers and a biotechnology company. She’ll explain how she does it and share stories from her fight for good science.

4:30 p.m. ET
Sponsor Speaker

Closing Remarks

Virtual
Giulio F. Draetta, M.D., Ph.D., chief scientific officer, The University of Texas MD Anderson Cancer Center

4:35 p.m. ET

Closing from STAT

Virtual

5:30 p.m. ET

In-person program - Registration opens

In-person - Attendee pass only

All in-person attendees will be asked to show a proof of Covid-19 vaccination upon arrival. Masks are required indoors throughout the event and reception. Drinks will be served.

6:30 p.m. ET

Program begins - Welcome from STAT

In-person - Attendee pass only

6:35 p.m. ET

To be announced

In-person - Attendee pass only
Featured speakers for in-person program to be announced.

7:25 p.m. ET

Program concludes - Closing from STAT

In-person - Attendee pass only

7:30 p.m. ET

Networking reception

In-person - Attendee pass only

Drinks and passed appetizers will be served. Attendees will be asked to indicate their comfort level for networking on their name badge.

November 17, 2021 - Virtual only

1:00 p.m. ET

Opening remarks

Virtual

1:05 p.m. ET

To be announced

Virtual

1:25 p.m. ET

Introducing the 2021 STAT Wunderkinds

Virtual
To be announced

Several young scientists from this year’s class of STAT Wunderkinds take the stage to share their work and hopes for the future of science and medicine.

Sponsor Introduction
Raghu Kalluri, M.D., Ph.D., chair of Cancer Biology, The University of Texas MD Anderson Cancer Center
1:55 p.m. ET

Interstitial

Virtual

2:00 p.m. ET

To be announced

Virtual

2:25 p.m. ET
Sponsor Session

Fireside chat

Virtual
David Chang, M.D., Ph.D., president, chief executive officer and co-Founder, Allogene Megan Thielking, news editor, STAT (moderator)

2:35 p.m. ET

To be announced

Virtual

3:00 p.m. ET

Coffee Break

Virtual

3:15 p.m. ET

Artificial Intelligence: The new sheriffs in town

Virtual
John Halamka, M.D., M.S., president, Mayo Clinic Platform Maia Hightower, M.D., MPH, MBA, chief medical information officer, University of Utah Health Nigam Shah, MBBS, Ph.D, professor of Medicine, Stanford University; associate CIO for data science, Stanford Health Care Casey Ross, national technology correspondent, STAT (moderator)

These academics are helping AI move out of its Wild West phase. For all the hype, there's relatively little research or oversight setting the bar for how AI should improve patient care. Here are some fixes.

3:50 p.m. ET

Interstitial

Virtual

3:55 p.m. ET
Sponsor Speaker

Spotlight Session

Virtual
James Kugler, chief digital officer, Merck KGaA Darmstadt and managing director of EMD Digital

4:00 p.m. ET

Demo: What this dummy tells us about Covid-19’s spread

Virtual
Linsey Marr, Ph.D., professor of civil and environmental engineering, Virginia Tech

One of the biggest questions of the pandemic: to what degree is the virus spread in droplets, and to what degree does it become airborne? The answer may come from these specialized dummies used to study the physics of virus transmission.

4:15 p.m. ET

To be announced

Virtual

4:40 p.m. ET
Sponsor Session

Fireside Chat

Virtual
Stephen J. Ubl, president and chief executive officer, PhRMA Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)

4:50 p.m. ET

The company builder behind Moderna

Virtual
Noubar Afeyan, Ph.D., founder and CEO, Flagship Pioneering & co-founder and chairman, Moderna Linda Henry, CEO, Boston Globe Media Partners (moderator)

Under founder Noubar Afeyan, Flagship Pioneering has become a prolific and successful assembly line for biotechnology firms, including Agios, Acceleron, and, of course, Moderna. Hear his thoughts on his journey and the future of biotech.

5:20 p.m. ET

Closing remarks

Virtual

November 18, 2021 - Virtual only

1:00 p.m. ET

Welcome remarks

Virtual

1:05 p.m. ET

To be announced

Virtual

1:25 p.m. ET
Sponsor Session

Fireside chat

Virtual
Liz Barrett, president and chief executive officer, UroGen Pharma Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)

1:35 p.m. ET

Interstitial

Virtual

1:40 p.m. ET

Race and the future of cancer screening

Virtual
Kevin Conroy, chief executive officer, president, and chairman of the board, Exact Sciences Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)

As he turned 30, STAT reporter Nicholas St. Fleur got a colonoscopy. The reason behind this odd birthday gift provides a window into both the rise of colorectal cancer in young Americans and the disproportionate risk that Black people face with the disease. Here, he’ll look at the future of colorectal cancer screening, including detecting cancer in stool or even with a blood test.

2:10 p.m. ET

To be announced

Virtual

2:35 p.m. ET
Sponsor Speaker

Spotlight Session

Virtual
Teresa Bitetti, president, global oncology business unit, Takeda

2:40 p.m. ET

To be announced

Virtual

3:05 p.m. ET

Coffee Break

Virtual

3:20 p.m. ET

To be announced

Virtual

4:10 p.m. ET
Sponsor speaker

Spotlight Session

Virtual
Sastry Chilukuri, co-CEO, President Acorn AI at MEDIDATA, Dassault Systèmes

4:15 p.m. ET

To be announced

Virtual

4:40 p.m. ET
Sponsor Session

Fireside chat

Virtual
Darryl Sleep, senior vice president global medical and chief medical officer, Amgen Rick Berke, co-founder and executive editor, STAT (moderator)

4:50 p.m. ET

To be announced

Virtual

5:20 p.m. ET
Sponsor Speaker

Closing remarks

Virtual

5:25 p.m. ET

Closing from STAT

Virtual

Location

Hybrid Event

This year’s STAT Summit will have virtual and in-person components. The majority of programming will take place via live-stream. There will be an in-person event held at the BSA Space in Boston’s Financial District. We are continually monitoring the situation, and will alert ticket holders of any changes.

Details about these options are available in the “Attend” section below.

© Mapbox © OpenStreetMap

 

Attend

Register to attend the STAT Summit

If you’re a STAT+ subscriber, use your STAT+ email address when you register for this event to unlock an exclusive 20% subscriber discount.

Viewer Pass $300

This pass provides virtual access only. With it, you’ll be able to:

  • Access live-streams of all main-stage programming via our virtual event platform
  • Network with fellow attendees and browse sponsor booths via STAT's virtual event platform
  • Chat with fellow viewer and attendee passholders, ask questions during live programming, and respond to polls throughout the event.

You will NOT have access to the in-person programming and networking reception on Nov. 16, nor the exclusive breakout session at noon on Nov. 18.

Attendee Pass, by application only $600

This pass allows for complete, hybrid access to the event. With it, you get all the benefits of the Viewer Pass, plus:

  • An invitation to an exclusive in-person program and networking reception to be held in Boston, MA on the evening of Nov. 16 (Day 1 of the Summit).
  • Access to one virtual breakout session on Nov. 18 (Day 3 of the Summit).
  • A complimentary STAT Summit welcome gift which will be mailed to you (while supplies last, U.S. shipping only).
  • Early access to the STAT virtual event platform.

How it works

Everyone must first purchase a Viewer Pass to attend the event. If you’re interested in an Attendee Pass, select “Yes, I’d like to apply” at checkout and complete the application. If your application is accepted, we will be in touch with next steps for upgrading your ticket.


Get our Morning Rounds newsletter

A free, daily guide to news in health and medicine

Sponsors

A special thanks to our partners

Presenting Sponsor

STAT Wunderkinds Sponsor

STAT Biomedical Innovation
Award Sponsor

Premium Sponsors

Supporting Sponsor

Contact

Stay in the loop

Join our email list

Sign up today for summit news and updates

Please enter a valid email address.

Questions?

Email us any questions or concerns

[email protected]

Terms & Conditions